Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CTCX Carmell	$3.63 -16.0%	$2.72	$0.17 ▼ $1.27	$75.89M	0.51	4.62 million shs	333,513 shs
LAKE Lakeland Industries	$14.41 +1.9%	$15.88	$12.76 ▼ $27.28	$134.54M	1.01	94,256 shs	119,233 shs
OBIO Orchestra BioMed	$3.20 +1.3%	$2.99	$2.37 ▼ $8.30	$121.07M	0.61	181,241 shs	60,500 shs
PEYE Precision Optics		$0.00	$1.61 ▼ $2.69	$32.98M	0.41	9,793 shs	113,500 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CTCX Carmell	0.00%	+35.45%	+50.62%	+1,942.77%	+233.03%
LAKE Lakeland Industries	+0.71%	+2.61%	+6.32%	-10.51%	-37.38%
OBIO Orchestra BioMed	+2.27%	+4.29%	+4.98%	+10.49%	-60.65%
PEYE Precision Optics	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CTCX Carmell	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LAKE Lakeland Industries	4.7276 of 5 stars	3.5	1.0	0.8	4.9	1.5	3.3	2.5
OBIO Orchestra BioMed	2.9144 of 5 stars	3.6	5.0	0.0	0.0	0.0	1.7	0.0
PEYE Precision Optics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CTCX Carmell	0.00	N/A	N/A	N/A
LAKE Lakeland Industries	3.00	Buy	$26.00	80.43% Upside
OBIO Orchestra BioMed	3.20	Buy	$14.20	343.75% Upside
PEYE Precision Optics	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest PEYE, LAKE, CTCX, and OBIO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/10/2025	LAKE Lakeland Industries	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$30.00 ➝ $26.00
5/13/2025	OBIO Orchestra BioMed	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00
5/5/2025	OBIO Orchestra BioMed	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$16.00 ➝ $12.00
4/23/2025	OBIO Orchestra BioMed	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/22/2025	OBIO Orchestra BioMed	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00 ➝ $20.00

(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CTCX Carmell	$32.84K	2,310.82	N/A	N/A	$1.07 per share	3.39
LAKE Lakeland Industries	$167.21M	0.82	$1.09 per share	13.25	$15.44 per share	0.93
OBIO Orchestra BioMed	$2.64M	46.44	N/A	N/A	$0.87 per share	3.68
PEYE Precision Optics	$15.68M	0.00	N/A	N/A	$0.53 per share	0.00

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CTCX Carmell	-$15.44M	N/A	0.00	∞	N/A	N/A	-217.50%	-50.22%	N/A
LAKE Lakeland Industries	-$18.08M	-$3.01	N/A	8.68	N/A	-13.31%	-6.88%	-4.47%	9/3/2025 (Estimated)
OBIO Orchestra BioMed	-$61.02M	-$1.78	N/A	N/A	N/A	-2,297.85%	-189.26%	-93.76%	N/A
PEYE Precision Optics	-$930K	-$0.06	N/A	N/A	N/A	-5.93%	-12.10%	-6.41%	N/A

Latest PEYE, LAKE, CTCX, and OBIO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
6/9/2025	Q1 2026	LAKE Lakeland Industries	$0.27	-$0.41	-$0.68	-$0.41	$48.84 million	$46.75 million
5/12/2025	Q1 2025	OBIO Orchestra BioMed	-$0.46	-$0.49	-$0.03	-$0.49	$0.39 million	$0.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CTCX Carmell	N/A	N/A	N/A	N/A	N/A
LAKE Lakeland Industries	$0.12	0.83%	N/A	N/A	1 Years
OBIO Orchestra BioMed	N/A	N/A	N/A	N/A	N/A
PEYE Precision Optics	N/A	N/A	N/A	N/A	N/A

Latest PEYE, LAKE, CTCX, and OBIO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2025	LAKE Lakeland Industries	quarterly	$0.03	0.71%	5/15/2025	5/15/2025	5/22/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CTCX Carmell	N/A	0.31	0.29
LAKE Lakeland Industries	0.17	3.88	1.51
OBIO Orchestra BioMed	0.85	3.35	3.34
PEYE Precision Optics	0.23	1.42	0.76

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CTCX Carmell	24.22%
LAKE Lakeland Industries	71.69%
OBIO Orchestra BioMed	53.55%
PEYE Precision Optics	N/A

Insider Ownership

Company	Insider Ownership
CTCX Carmell	29.00%
LAKE Lakeland Industries	1.91%
OBIO Orchestra BioMed	8.10%
PEYE Precision Optics	22.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CTCX Carmell	14	20.91 million	14.84 million	Not Optionable
LAKE Lakeland Industries	2,100	9.51 million	9.33 million	Optionable
OBIO Orchestra BioMed	4	38.31 million	35.21 million	Not Optionable
PEYE Precision Optics	80	16.92 million	13.08 million	Not Optionable

PEYE, LAKE, CTCX, and OBIO Headlines

Recent News About These Companies

German Precision Optics Passion ED 8x42 Binocular

July 1, 2025 | birdguides.comB

LaCroix Precision Optics Expanding Manufacturing Operations in Batesville

June 9, 2025 | armoneyandpolitics.comA

Tag: LaCroix Precision Optics

June 6, 2025 | talkbusiness.netT

LaCroix Precision Optics expanding in Batesville, adding 107 jobs

June 6, 2025 | talkbusiness.netT

LaCroix Precision Optics announces $13.8M expansion, creating 107 jobs in Batesville

June 6, 2025 | msn.com

Precision Optics Corporation Third Quarter 2025 Earnings: US$0.30 loss per share (vs US$0.052 loss in 3Q 2024)

May 17, 2025 | uk.finance.yahoo.com

Precision Optics Corporation, Inc. (NASDAQ:POCI) Q3 2025 Earnings Call Transcript

May 17, 2025 | msn.com

Q3 2025 Precision Optics Corporation Inc Earnings Call

May 16, 2025 | uk.finance.yahoo.com

Precision Optics Enters into Main Purchase Agreement with Top Tier Aerospace Customer and Expands Program Backlog to $6.6 Million

April 3, 2025 | manilatimes.netM

Precision Optics appoints Joseph Pellegrino to board of directors

March 21, 2025 | markets.businessinsider.com

Rochester Precision Optics looks global with $50M funding commitment

March 5, 2025 | optics.orgO

Precision Optics Corporation, Inc. (NASDAQ:POCI) Q2 2025 Earnings Call Transcript

February 17, 2025 | msn.com

Precision Optics Corporation Second Quarter 2025 Earnings: US$0.15 loss per share (vs US$0.13 loss in 2Q 2024)

February 15, 2025 | finance.yahoo.com

Precision Optics Corporation: Precision Optics Reports Second Quarter Fiscal Year 2025 Financial Results

February 15, 2025 | finanznachrichten.de

Precision Optics Corporation, Inc. (POCI) Q2 2025 Earnings Call Transcript

February 14, 2025 | seekingalpha.com

Q2 2025 Precision Optics Corporation Inc Earnings Call

February 14, 2025 | finance.yahoo.com

Precision Optics launches endoscopic platform

January 28, 2025 | msn.com

Precision Optics Corporation And 2 More Promising US Penny Stocks

November 13, 2024 | finance.yahoo.com

New Spectral Camera Uses AI to Boost Farm Yields by 20%

November 6, 2024 | msn.com

Micro Eyewear Inc.: Making Eyeglasses That Bring Clarity to See Future Opportunities

November 5, 2024 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Defense Leaders Set to Gain From Rising Military Spend
By Chris Markoch | July 5, 2025
View 3 Defense Leaders Set to Gain From Rising Military Spend
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
3 Semiconductor Stocks Poised to Surge on AI Spending
By Chris Markoch | June 25, 2025
View 3 Semiconductor Stocks Poised to Surge on AI Spending
Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
By Gabriel Osorio-Mazilli | June 29, 2025
View Snowflake Hits 52-Week High—Options Traders Bet on Further Rally

PEYE, LAKE, CTCX, and OBIO Company Descriptions

Carmell NASDAQ:CTCX

$3.63 -0.69 (-15.97%)

As of 07/18/2025

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Lakeland Industries NASDAQ:LAKE

$14.41 +0.27 (+1.91%)

Closing price 04:00 PM Eastern

Extended Trading

$14.02 -0.39 (-2.71%)

As of 04:07 PM Eastern

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

Orchestra BioMed NASDAQ:OBIO

$3.20 +0.04 (+1.27%)

Closing price 04:00 PM Eastern

Extended Trading

$3.18 -0.02 (-0.59%)

As of 05:54 PM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Precision Optics OTCMKTS:PEYE

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time